ConductScience.org, home

Trial · NCT07882836

Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG

NCT07882836, Not applicable, Not yet recruiting, Izmir Katip Celebi University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG. Trials, record NCT07882836. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882836

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG
NCT number
NCT07882836
Status
Not yet recruiting
Phases
Not applicable
Enrollment
180 participants, estimated
Lead sponsor
Izmir Katip Celebi University
Conditions
Chronic Poststernotomy Pain
Interventions
Pecto-Intercostal Fascial Plane Block, Standardized Multimodal Systemic Analgesia
First posted
2026-10-20
Last updated
2026-10-20

Source ClinicalTrials.gov

Registered outcomes32

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Clinically Significant Chronic Poststernotomy PainPostoperative Day 90
The proportion of participants with clinically significant chronic poststernotomy pain on postoperative day 90 will be assessed. Clinically significant chronic poststernotomy pain will be defined as pain that develops after surgery or is aggravated by surgery; is localized to the sternotomy line, parasternal region, chest tube insertion sites, or thoracic wall area related to internal thoracic artery dissection; persists or recurs at 3 months after surgery; and has an average intensity of at least 3 on the 0-10 Numeric Rating Scale (NRS) during the preceding 7 days. Pain better explained by sternal wound infection, mediastinitis, sternal instability or nonunion, recurrent myocardial ischemia, malignancy, or another clinical condition will not be classified as chronic poststernotomy pain. The outcome will be assessed by an outcome assessor blinded to treatment allocation. Higher incidence indicates a less favorable outcome.
SecondaryPostoperative Pain Intensity at Rest6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5Pain intensity at rest will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
SecondaryPostoperative Pain Intensity During Coughing or Deep Breathing6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5
Pain intensity during coughing or deep breathing will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
SecondaryPostoperative Pain Intensity During Mobilization6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5
Pain intensity during mobilization will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. Mobilization pain will be assessed only when mobilization is clinically feasible.
SecondaryIntraoperative Opioid ConsumptionIntraoperative periodTotal opioid consumption administered during surgery will be recorded and converted to morphine milligram equivalents (MME). Higher values indicate greater opioid consumption.
SecondaryRequirement for Rescue AnalgesiaFrom the end of surgery through postoperative day 5 or hospital discharge, whichever occurs first
The proportion of participants requiring at least one rescue analgesic intervention will be recorded. The protocol-defined primary criterion for rescue analgesia is a score of 4 or higher on the 0-10 Numeric Rating Scale (NRS) at rest or during coughing or movement; rescue analgesia may also be administered according to clinical need irrespective of the NRS threshold.
SecondaryNumber of Rescue Analgesic AdministrationsFrom the end of surgery through postoperative day 5 or hospital discharge, whichever occurs firstThe total number of rescue analgesic administrations received by each participant during the assessment period will be recorded. Higher values indicate greater rescue analgesic requirements.
SecondaryTime to First Rescue AnalgesiaFrom the end of surgery through postoperative day 5 or hospital discharge, whichever occurs first
Time from the end of surgery to the first administration of rescue analgesia will be recorded in hours. Participants who do not require rescue analgesia during the observation period will be recorded as having no rescue analgesic event during that period.
SecondaryIncidence of Postoperative NauseaFrom the end of surgery through 120 hours after surgery or hospital discharge, whichever occurs firstThe proportion of participants experiencing at least one episode of postoperative nausea during the assessment period will be recorded.
SecondaryIncidence of Postoperative OversedationFrom the end of surgery through 5 days after surgery or hospital discharge, whichever occurs first
The proportion of participants experiencing at least one episode of clinically significant oversedation during the assessment period will be recorded. Oversedation will be defined as inability to be easily awakened, requirement for repeated stimulation, or sedation sufficiently severe to cause clinically significant impairment of communication.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882836

GET https://conductscience.org/api/trials/v1/NCT07882836/registered?page=2